Latus Bio

Latus develops gene therapies using engineered adeno-associated virus (AAV) capsids and optimized delivery routes designed to target specific cell types and tissues for treating genetic diseases. The company focuses on improving AAV gene therapy efficacy while reducing dose requirements, toxicity, and manufacturing costs compared to conventional approaches.